La catena delle opzioni mostra i dati chiave delle opzioni azionarie di AquaBounty Techs a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per AquaBounty Techs..

AquaBounty Techs (NASDAQ:AQB) Azioni, Catena delle Opzioni

AquaBounty Techs

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Technologies Inc

Aab National Co

News

Dividends

Cabot Corporation Board Increases Dividend From $0.43 to $0.45

JELD-WEN Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 180.95 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $776.00 million which beat the analyst consensus estimate of $767.97 million by 1.05 percent. This is a 19.09 percent decrease over sales of $959.10 million the same period last year.

Earnings

Earnings Beats

JELD

JELD-WEN Holding Q1 Adj. EPS $(0.17) Beats $(0.19) Estimate, Sales $776.00M Beat $767.97M Estimate

Bright Horizons Family (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFAM#NYSE">BFAM</a>) affirms FY2025 Adj EPS guidance from $3.95-$4.15 to $3.95-$4.15 vs $4.06 analyst estimate. Raises FY2025 sales outlook from $2.85 billion-$2.90 billion to $2.87 billion-$2.92 billion vs $2.88 billion estimate.

Guidance

BFAM

Bright Horizons Family Affirms FY2025 Adj EPS Guidance of $3.95-$4.15 vs $4.06 Est; Raises FY2025 Sales Guidance from $2.85B-$2.90B to $2.87B-$2.92B vs $2.88B Est

Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.20 by 5 percent. This is a 61.54 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $323.34 million which beat the analyst consensus estimate of $321.00 million by 0.73 percent. This is a 3.28 percent increase over sales of $313.07 million the same period last year.

CRD/A

Crawford Q1 Adj. EPS $0.21 Beats $0.20 Estimate, Sales $323.34M Beat $321.00M Estimate

HealthStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) lowers FY2025 sales outlook from $302.00 million-$307.00 million to $297.50 million-$303.50 million vs $304.62 million estimate.

HSTM

HealthStream Lowers FY2025 Sales Guidance from $302.00M-$307.00M to $297.50M-$303.50M vs $304.62M Est

HealthStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.16 by 12.5 percent. This is a 17.65 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $73.48 million which missed the analyst consensus estimate of $74.93 million by 1.93 percent. This is a 1.00 percent increase over sales of $72.76 million the same period last year.

Earnings Misses

HealthStream Q1 GAAP EPS $0.14 Misses $0.16 Estimate, Sales $73.48M Miss $74.93M Estimate

Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) (the "Company" or "Boot Barn") today announced that its Board of Directors has appointed John Hazen as Chief Executive Officer ("CEO"), effective May 5, 2025. Mr. Hazen had been serving as the Company's Interim Chief Executive Officer since November 2024.

Management

BOOT

Boot Barn Holdings Appoints John Hazen As CEO, Effective May 5, 2025

Tidewater (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) affirms FY2025 sales outlook from $1.32 billion-$1.38 billion to $1.32 billion-$1.38 billion vs $1.34 billion estimate.

Tidewater Affirms FY2025 Sales Guidance of $1.32B-$1.38B vs $1.34B Est

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) lowers FY2025 Adj EPS guidance from $7.40-$7.80 to $7.15-$7.50 vs $7.52 analyst estimate..

Cabot Lowers FY2025 Adj EPS Guidance from $7.40-$7.80 to $7.15-$7.50 vs $7.52 Est

Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) affirms FY2025 FFO guidance from $1.43-$1.46 to $1.43-$1.46 vs $1.46 analyst estimate..

SBRA

Sabra Health Care REIT Affirms FY2025 FFO Guidance of $1.43-$1.46 vs $1.46 Est

LTC Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTC#NYSE">LTC</a>) is looking for FY2025 FFO of $2.65-$2.69 vs $2.66 analyst estimate..

LTC Properties Sees FY2025 FFO $2.65-$2.69 vs $2.66 Est

Immuneering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.58) by 27.59 percent. This is a 14.29 percent increase over losses of $(0.49) per share from the same period last year.

IMRX

Immuneering Q1 EPS $(0.42) Beats $(0.58) Estimate

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.85 by 2.7 percent. This is a 6.74 percent increase over earnings of $1.78 per share from the same period last year. The company reported quarterly sales of $936.00 million which missed the analyst consensus estimate of $1.02 billion by 8.61 percent. This is a 8.15 percent decrease over sales of $1.02 billion the same period last year.

Cabot Q2 Adj. EPS $1.90 Beats $1.85 Estimate, Sales $936.00M Miss $1.02B Estimate

WIIM

TALO

Talos Energy shares are trading higher after the company reported better-than-expected Q1 financial results.

Tidewater (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.76 by 9.21 percent. This is a 6.74 percent decrease over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $333.44 million which beat the analyst consensus estimate of $323.60 million by 3.04 percent. This is a 3.82 percent increase over sales of $321.16 million the same period last year.

Tidewater Q1 EPS $0.83 Beats $0.76 Estimate, Sales $333.44M Beat $323.60M Estimate

STRL

Sterling Infrastructure shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance.

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed up 37.31% at $1.40</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 15.83% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 15.48% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 11.46% at $0.93</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 6.98% at $0.44</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 5.47% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 5.17% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.15% at $1.36</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed up 3.55% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 3.26% at $1.90</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 3.03% at $56.15</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 49.26% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 28.57% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 17.17% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 15.20% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 14.58% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 12.83% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 10.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 7.20% at $1.16</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 6.86% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 6.00% at $0.21</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed down 5.99% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 5.32% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 5.26% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 4.24% at $7.42</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 3.85% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed down 3.60% at $1.35</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 3.03% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

BBRRF

BLOZF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CLSH

CNBX

CRBP

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CXXIF

FFNTF

FUAPF

GNLN

GRWG

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LMLLF

MGWFF

MRMD

NWVCF

OILFF

RMHB

RSSFF

SNDL

SOLCF

TGIFF

XXII

Bearish Monday For Marijuana Stocks - Maple Leaf Green World, 22nd Century Group Among Top Gainers

BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) affirms FY2025 sales outlook from $395.00 million-$425.00 million to $395.00 million-$425.00 million vs $406.50 million estimate.

BRCC

BRC Affirms FY2025 Sales Guidance of $395.00M-$425.00M vs $406.50M Est

Upwork, Inc.&nbsp; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) released its first-quarter results after Monday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/05/g45206225/upwork-reports-first-quarter-2025-financial-results">details from the report.&nbsp;</a>
The Details:&nbsp;Upwork reported quarterly earnings of&nbsp;34&nbsp;cents per share which beat the analyst consensus estimate of&nbsp;26&nbsp;cents. Quarterly revenue came in at $192.71 million,&nbsp;which beat the analyst consensus estimate of&nbsp;$188.32 million and is up from revenue of&nbsp;$190.94 million&nbsp;from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/earnings/25/05/45194998/saudi-arabias-oil-power-play-jolts-markets-can-diamondback-and-rivals-survive-the-squeeze?utm_source=articleShare">Saudi Arabia&#8217;s Oil Power Play Jolts Markets: Can Diamondback And Rivals Survive The Squeeze?</a>
The company reported 812,000 active clients and GSV per active client&nbsp;of $4,912, which increased 3% year-over-year, reflecting positive growth for the first time in six quarters.
&#8220;Upwork is off to a strong start in 2025, delivering record first-quarter results across revenue and profitability, a testament to the team&#8217;s accelerated execution and the resilience of our business model,&#8221; said Hayden Brown, CEO of Upwork. 
&#8220;We are incredibly excited by the early impact of our strategic product investments in AI, which are already enhancing customer productivity and engagement. With positive momentum across our business and a winning strategy for AI innovation, we are confident in our path to expand market share, drive ongoing profitability, and continue to be the category leader at the intersection of talent, technology and work,&#8221; Brown added.
Outlook:&nbsp;Upwork raised its fiscal 2025 adjusted earnings per share guidance from a range of $1.05 to $1.10&nbsp;to&nbsp;a range of $1.14 to $1.18, versus the&nbsp;$1.07&nbsp;analyst estimate. The company affirmed its fiscal year revenue guidance of $740 million to $760 million, versus the&nbsp;$750.22 million&nbsp;estimate.
UPWK Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Upwork stock was up 11.49% after hours at $14.85 on Monday.&nbsp;&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/management/25/05/45180224/these-ev-makers-could-shine-if-musk-leaves-tesla?utm_source=articleShare">These EV Makers Could Shine If Musk Leaves Tesla</a></li>
</ul>
Image: Shutterstock

Comments

AquaBounty Techs

AquaBounty Techs (AQB) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO